Manages anxiety disorders. ANDA 85472, held by Bausch. Chlordiazepoxide Hydrochloride.
As of Nov 16, 2026, ANDA 85472 (Librium), held by Bausch, was first approved by FDA on Sep 21, 1977, with 19 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Chlordiazepoxide hydrochloride capsules are indicated for the management of anxiety disorders or for the short term relief of symptoms of anxiety, withdrawal symptoms of acute alcoholism, and preoperative apprehension and anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. The effectiveness of chlordiazepoxide hydrochloride capsules in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 21, 1977 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Librium10MG · capsule;oral | Chlordiazepoxide Hydrochloride | RxReference drug |
| Jan 17, 2023 | Supplement 50Labeling · Standard review | Approved | None posted |
| Feb 5, 2021 | Supplement 48Labeling · Standard review | Approved | None posted |
| Dec 16, 2016 | Supplement 47Labeling · Standard review | Approved | None posted |
| Sep 26, 2002 | Supplement 43Labeling | Approved | None posted |
| Sep 26, 2002 | Supplement 42Manufacturing | Approved | None posted |
| Sep 26, 2002 | Supplement 41Manufacturing | Approved | None posted |
| Sep 26, 2002 | Supplement 40Manufacturing | Approved | None posted |
| Nov 28, 1997 | Supplement 38Manufacturing | Approved | None posted |
| Oct 20, 1997 | Supplement 39Manufacturing | Approved | None posted |
| Nov 3, 1994 | Supplement 37Labeling | Approved | None posted |
| Mar 27, 1991 | Supplement 36Manufacturing | Approved | None posted |
| Feb 6, 1989 | Supplement 35Labeling | Approved | None posted |
| Apr 1, 1988 | Supplement 33Labeling | Approved | None posted |
| Nov 2, 1987 | Supplement 32Manufacturing | Approved | None posted |
| Jun 7, 1984 | Supplement 30Manufacturing | Approved | None posted |
| Jun 9, 1983 | Supplement 29Manufacturing | Approved | None posted |
| Jul 14, 1982 | Supplement 28Manufacturing | Approved | None posted |
| May 14, 1982 | Supplement 26Manufacturing | Approved | None posted |
| Mar 30, 1982 | Supplement 25Manufacturing | Approved | None posted |
| Sep 21, 1977 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters